Učitavanje...
Clinical validity of detecting circulating tumor cells by AdnaTest assay compared to direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
Circulating tumor cell (CTC) number measured with the CellSearch(®) assay is prognostic for survival in metastatic castration-resistant prostate cancer (mCRPC) pre- and post-therapy. Using a standard operating protocol for sample collection, processing, and analysis, we compared detection rates of C...
Spremljeno u:
| Izdano u: | Cancer J |
|---|---|
| Glavni autori: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5108569/ https://ncbi.nlm.nih.gov/pubmed/27749322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000220 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|